Regeneron Pharmaceuticals Stock Forecast

Buy or Hold candidate since Oct 14, 2025 Gain 23.00%

The Regeneron Pharmaceuticals stock price gained 1.56% on the last trading day (Monday, 17th Nov 2025), rising from $693.50 to $704.31. During the last trading day the stock fluctuated 2.82% from a day low at $692.29 to a day high of $711.83. The price has risen in 7 of the last 10 days and is up by 9.66% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 209 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $784.95 million.

The stock has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $686.26, a level that may pose a second chance to hit a runner. According to fan-theory $778.68 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

REGN Signals & Forecast

Mostly positive signals in the chart today. The Regeneron Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $680.19 and $614.27. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, November 04, 2025, and so far it has risen 12.15%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Regeneron Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $654.48 and $600.00. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Regeneron Pharmaceuticals finds support just below today's level at $654.48. If this is broken, then the next support from accumulated volume will be at $600.00 and $591.99.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $19.54 between high and low, or 2.82%. For the last week, the stock has had daily average volatility of 3.21%.

Our recommended stop-loss: $679.24 (-3.56%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 9 days ago.)

Trading Expectations (REGN) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Regeneron Pharmaceuticals to open at $702.81, and during the day (based on 14 day Average True Range), to move between $694.36 and $714.26, which gives a possible trading interval of +/-$19.90 (+/-2.87%) up or down from last closing price. If Regeneron Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 2.87% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $654.48, some $49.83 (7.08%) from the current price of $704.31, our system finds the risk reward attractive.

Dividend Warning For REGN

Dividend warning for REGN: Ex-dividend date is approaching in 1 day on Thursday 20th November, 2025. The dividend to be paid is $0.88, which is a small dividend (0.125%). The stock is expected to open approximately 0.125% lower on the ex-dividend date.

Is Regeneron Pharmaceuticals stock A Buy?

Regeneron Pharmaceuticals holds several positive signals and has broken the strong rising trend up. As the stock is also in great technical shape we, therefore, consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.814 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $702.81 ( 0.213%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk